Chimerix
Home
about Chimerix
About Chimerix
Strategy
Licensing Opportunities
Commitment
Management Team
Board of Directors
Scientific Advisory Board
Investors
Therapeutic Programs
Pipeline
CMX001
CMV & BK Virus
Smallpox
CMX001 Publications & Presentations
CMX157
HIV
CMX157 Publications & Presentations
Research Programs
Publications & Presentations
Clinical Trials
Scientific Foundation
News & Resources
News Releases
Events
Careers
Working at Chimerix
Opportunities
Contact Us
Scientific Foundation
Scientific Foundation
PIM Conjugate Technology
Chimerix Chemical Library
Patents
Home
Scientific Foundation
Featured News & Events
Chimerix appoints two new Vice Presidents to Clinical Management Team
Chimerix initiates Phase 1 Study CMX157
Chimerix appoints Thomas Pitler, Ph.D., VP, Business Development
Chimerix names George Painter, PhD, Chairman of the Board & CSO; appoints Kenneth Moch, President & CEO
